Taiwan Frank Douglas, CEO of the TheVax, discusses what he finds so inspiring about innovation in resource-constrained environments, and this Taiwanese biotech’s revolutionary SIT specific immunotherapy platform. The company was founded in 2012 with the mission to focus on the use of immunotherapy to address virus-induced tumors and infections in patients.…
See our Cookie Privacy Policy Here